tiprankstipranks
Trending News
More News >
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA
Australian Market

Arovella Therapeutics Limited (ALA) Financial Statements

Compare
16 Followers

Arovella Therapeutics Limited Financial Overview

Arovella Therapeutics Limited's market cap is currently AU$108.11M. The company's EPS TTM is AU$-0.006; its P/E ratio is -13.24; Arovella Therapeutics Limited is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 136.00KAU$ 17.00KAU$ 405.90KAU$ 295.81KAU$ 257.35K
Gross ProfitAU$ 136.00KAU$ -25.98KAU$ -3.00MAU$ 88.75KAU$ 34.60K
Operating IncomeAU$ -11.20MAU$ -10.81MAU$ -9.68MAU$ -7.59MAU$ -2.99M
EBITDAAU$ -11.10MAU$ -10.63MAU$ -10.37MAU$ -7.87MAU$ -4.99M
Net IncomeAU$ -7.51MAU$ -8.75MAU$ -10.18MAU$ -8.62MAU$ -5.05M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 20.88MAU$ 12.71MAU$ 5.18MAU$ 6.07MAU$ 6.72M
Total AssetsAU$ 21.60MAU$ 13.28MAU$ 5.47MAU$ 9.21MAU$ 10.69M
Total DebtAU$ 0.00AU$ 0.00AU$ 144.80KAU$ 144.80KAU$ 79.23K
Net DebtAU$ -20.88MAU$ -12.71MAU$ -5.18MAU$ -5.93MAU$ -6.64M
Total LiabilitiesAU$ 1.52MAU$ 2.06MAU$ 1.69MAU$ 1.60MAU$ 1.71M
Stockholders' EquityAU$ 20.08MAU$ 11.23MAU$ 3.78MAU$ 7.62MAU$ 8.98M
Cash Flow
Free Cash FlowAU$ -7.34MAU$ -7.04MAU$ -6.40MAU$ -6.83MAU$ -4.06M
Operating Cash FlowAU$ -6.93MAU$ -6.91MAU$ -6.40MAU$ -6.27MAU$ -3.54M
Investing Cash FlowAU$ -432.11KAU$ -179.34KAU$ 95.42KAU$ -566.00KAU$ -514.55K
Financing Cash FlowAU$ 15.52MAU$ 14.61MAU$ 5.41MAU$ 6.19MAU$ 9.80M
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

Arovella Therapeutics Limited Debt to Assets

Arovella Therapeutics Limited Cash Flow

Arovella Therapeutics Limited Forecast EPS vs Actual EPS